Cargando…

The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome

INTRODUCTION: Available evidence suggests that the renin–angiotensin–aldosterone (RAA) system is a good target for medical intervention on aortic root dilatation in Marfan syndrome (MFS). The effect of Compound 21 (C21), a nonpeptide angiotensin II type 2 receptor agonist, on aneurysm progression wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verbrugghe, Peter, Verhoeven, Jelle, Clijsters, Marnick, Vervoort, Dominique, Schepens, Jarne, Meuris, Bart, Herijgers, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902135/ https://www.ncbi.nlm.nih.gov/pubmed/29300219 http://dx.doi.org/10.1097/FJC.0000000000000560

Ejemplares similares

An electro-responsive hydrogel for intravascular applications: an in vitro and in vivo evaluation
por: Verbrugghe, Peter, et al.
Publicado: (2015)

Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
por: Erickson-Miller, Connie L, et al.
Publicado: (2009)

A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain
por: Hilfiger, Louis, et al.
Publicado: (2020)

In vitro pharmacological characterization of a novel unbiased NOP receptor‐selective nonpeptide agonist AT‐403
por: Ferrari, Federica, et al.
Publicado: (2017)

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
por: Kawai, Takahiro, et al.
Publicado: (2020)

A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism
por: Juliana, Christine A., et al.
Publicado: (2023)

Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury
por: Barroso, Lívia Corrêa, et al.
Publicado: (2012)

Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors
por: Journigan, V. Blair, et al.
Publicado: (2014)

Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms
por: Gomez, Delphine, et al.
Publicado: (2011)

Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome
por: Asano, Keiichi, et al.
Publicado: (2022)

AVE0991, a Nonpeptide Angiotensin 1-7 Receptor Agonist, Improves Glucose Metabolism in the Skeletal Muscle of Obese Zucker Rats: Possible Involvement of Prooxidant/Antioxidant Mechanisms
por: Dobrocsyova, Viktoria, et al.
Publicado: (2020)

The revised role of TGF-β in aortic aneurysms in Marfan syndrome
por: Franken, R., et al.
Publicado: (2014)

Marfan Syndrome - Acute Aortic Dissection Due to Giant Aortic Aneurysm
por: MUNTEANU, O., et al.
Publicado: (2017)

Automated Delineation of Vessel Wall and Thrombus Boundaries of Abdominal Aortic Aneurysms Using Multispectral MR Images
por: Rodriguez-Vila, B., et al.
Publicado: (2015)

Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
por: Jost, Christine H. Attenhofer, et al.
Publicado: (2014)

Ruptured abdominal aortic aneurysm repair in pediatric Marfan syndrome patient
por: Lu, Joyce J., et al.
Publicado: (2018)

Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome
por: Jespersen, Kathryn, et al.
Publicado: (2022)

Angiotensin, transforming growth factor β and aortic dilatation in Marfan syndrome: Of mice and humans()
por: Yu, Christopher, et al.
Publicado: (2018)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
por: Giorgioni, Gianfabio, et al.
Publicado: (2022)

SAT-169 Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists Suppress Glucose- and Sulfonylurea-Induced Insulin Secretion in Rats
por: Sturchler, Emmanuel, et al.
Publicado: (2019)

MON-089 Discovery and Identification of Late Stage Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists for the Treatment of Hyperinsulinemic Hypoglycemia
por: Fowler, Melissa A, et al.
Publicado: (2020)

Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers
por: Madan, Ajay, et al.
Publicado: (2022)

Oxidative Stress-Related Susceptibility to Aneurysm in Marfan’s Syndrome
por: Rysz, Jacek, et al.
Publicado: (2021)

Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome
por: Soto, María E., et al.
Publicado: (2018)

Giant Ascending Aortic Aneurysm with Painless Dissection in a Patient with Marfan Syndrome
por: Algarni, Khaled D., et al.
Publicado: (2020)

Thoracic Aortic Aneurysm Surgery in Marfan Patients: a Perspective from the UK
por: Harky, Amer, et al.
Publicado: (2020)

Non-Dissecting Distal Aortic and Peripheral Arterial Aneurysms in Patients With Marfan Syndrome
por: Pellenc, Quentin, et al.
Publicado: (2022)

Targeting Staphylococcus aureus Quorum Sensing with Nonpeptidic Small Molecule Inhibitors
por: Murray, Ewan J., et al.
Publicado: (2014)

PSUN304 CRN04777 an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
por: Ferrara-Cook, Christine, et al.
Publicado: (2022)

Dissecting aortic aneurysm in Marfan syndrome is associated with losartan-sensitive transcriptomic modulation of aortic cells
por: Sun, Yifei, et al.
Publicado: (2023)

Long-term outcomes of surgical procedures for Marfan syndrome: aortic dissection versus aneurysm
por: Li, Ning, et al.
Publicado: (2020)

Marfan Syndrome, Giant Ascending Aortic Aneurysm, and Left Ventricular Noncompaction: The Heart in Jeopardy!
por: Belharty, Najlaa, et al.
Publicado: (2023)

Marfan syndrome with a giant noncoronary sinus of Valsalva aneurysm
por: Avsar, Sahin, et al.
Publicado: (2015)

Blood pressure‐independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan
por: Tehrani, Arash Y., et al.
Publicado: (2021)

Pharmacophore Modeling and Docking Studies on Some Nonpeptide-Based Caspase-3 Inhibitors
por: Sharma, Simant, et al.
Publicado: (2013)

Avoiding oversizing in sutureless valves leads to lower transvalvular gradients and less permanent pacemaker implants postoperatively
por: Szecel, Delphine, et al.
Publicado: (2022)

Personal resources and satisfaction with life in Marfan syndrome patients with aortic pathology and in abdominal aortic aneurysm patients
por: Stanišić, Michał-Goran, et al.
Publicado: (2018)

β-blockers and Angiotensin Converting Enzyme Inhibitors: Comparison of Effects on Aortic Growth in Pediatric Patients with Marfan Syndrome
por: Phomakay, Venusa, et al.
Publicado: (2014)

The Beneficial Effect of Renin-Angiotensin-Aldosterone System Blockade in Marfan Syndrome Patients after Aortic Root Replacement
por: Lee, Seung-Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_as8sha6su9289koageo4vks557